CY1110194T1 - Ενωσεις ιδιαιτερα χρησιμες για την αγωγη ή προληψη του μεταβολικου συνδρομου - Google Patents
Ενωσεις ιδιαιτερα χρησιμες για την αγωγη ή προληψη του μεταβολικου συνδρομουInfo
- Publication number
- CY1110194T1 CY1110194T1 CY20101100523T CY101100523T CY1110194T1 CY 1110194 T1 CY1110194 T1 CY 1110194T1 CY 20101100523 T CY20101100523 T CY 20101100523T CY 101100523 T CY101100523 T CY 101100523T CY 1110194 T1 CY1110194 T1 CY 1110194T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prevention
- metabolic syndrome
- enzyme inhibitor
- oxidase enzyme
- amine oxidase
- Prior art date
Links
- 208000001145 Metabolic Syndrome Diseases 0.000 title abstract 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 102000004316 Oxidoreductases Human genes 0.000 abstract 4
- 108090000854 Oxidoreductases Proteins 0.000 abstract 4
- 229940125532 enzyme inhibitor Drugs 0.000 abstract 4
- 239000002532 enzyme inhibitor Substances 0.000 abstract 4
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
Abstract
Η εφεύρεση αφορά την χρήση ενός αναστολέα ενζύμου αμιινοξειδάσης για την παραγωγή ενός φαρμακευτικού σκευάσματος, χρήσιμου στην αγωγή ή την πρόληψη του μεταβολικού συνδρόμου και ασθενειών ή παθήσεων, οι οποίες προκύπτουν απ' αυτό. Η εφεύρεση αφορά επίσης την χρήση της βιταμίνης Β1 ή ενός μεταβολίτη αυτής για την παραγωγή ενός φαρμακευτικού σκευάσματος χρήσιμου ως αναστολέα ενζύμου αμιινοξειδάσης. Επιπλέον η εφεύρεση αφορά ένα προϊόν τροφίμου, το οποίο περιέχει έναν αναστολέα ενζύμου αμιινοξειδάσης σε συνδυασμό με ένα τρόφιμο, μία προσθήκη τροφής, η οποία περιέχει έναν αναστολέα ενζύμου αμιινοξειδάσης σε συνδυασμό με έναν υγρό στερεό ή ημιστερεό φορέα.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20040136A FI20040136A0 (fi) | 2004-01-30 | 2004-01-30 | Erityisesti diabeetikoille soveltuvia koostumuksia |
| US57889604P | 2004-06-14 | 2004-06-14 | |
| EP05708123A EP1708711B1 (en) | 2004-01-30 | 2005-01-19 | Compositions useful especially for treatment or prevention of metabolic syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110194T1 true CY1110194T1 (el) | 2015-01-14 |
Family
ID=34828616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100523T CY1110194T1 (el) | 2004-01-30 | 2010-06-11 | Ενωσεις ιδιαιτερα χρησιμες για την αγωγη ή προληψη του μεταβολικου συνδρομου |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1708711B1 (el) |
| JP (1) | JP2007519688A (el) |
| AT (1) | ATE460935T1 (el) |
| CA (1) | CA2549029A1 (el) |
| CY (1) | CY1110194T1 (el) |
| DE (1) | DE602005019974D1 (el) |
| DK (1) | DK1708711T3 (el) |
| ES (1) | ES2342409T3 (el) |
| PL (1) | PL1708711T3 (el) |
| PT (1) | PT1708711E (el) |
| SI (1) | SI1708711T1 (el) |
| WO (1) | WO2005072738A1 (el) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8119651B2 (en) | 2004-01-30 | 2012-02-21 | Biotie Therapies Corp. | Compositions useful especially for treatment or prevention of metabolic syndrome |
| FI20060768A0 (fi) * | 2006-08-28 | 2006-08-28 | Faron Pharmaceuticals Oy | Erityisesti metabolia-oireyhtymän hoitoon tai ehkäisyyn soveltuvia koostumuksia |
| ITMI20050891A1 (it) * | 2005-05-17 | 2006-11-18 | Greenleaf S R L | Formulazioni per il trattamento di psoriasi |
| JPWO2009051223A1 (ja) * | 2007-10-19 | 2011-03-03 | 株式会社アールテック・ウエノ | 白内障処置のための医薬組成物 |
| UA112154C2 (uk) | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
| AU2010296420A1 (en) | 2009-09-16 | 2012-03-22 | Astellas Pharma Inc. | Glycine compound |
| CN107209875B (zh) | 2014-08-04 | 2020-10-09 | 联邦科学及工业研究组织 | 配制膳食食品的方法 |
| CN108299485B (zh) * | 2018-02-09 | 2020-05-12 | 湖北大学 | 一种用于检测活细胞内过氧化氢的荧光探针及其制备方法和应用 |
| WO2021059275A1 (en) * | 2019-09-26 | 2021-04-01 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Thiamine therapy for fatty liver associated diseases |
| CN110713986B (zh) * | 2019-11-12 | 2023-05-12 | 江南大学 | 一株维生素b1单克隆抗体杂交瘤细胞株cbdd及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5441883A (en) * | 1977-09-05 | 1979-04-03 | Takeda Chem Ind Ltd | Thiamine derivative and its preparation |
| US4558050A (en) * | 1984-03-01 | 1985-12-10 | University Of Florida | Treatment of metabolic disorders with dichloroacetate-thiamine preparations |
| JPH01104142A (ja) * | 1987-10-19 | 1989-04-21 | Seibutsu Shigen Kenkyusho:Kk | 消臭機能性食品及びその製造法 |
| JP3942257B2 (ja) * | 1998-01-06 | 2007-07-11 | 希能 澤口 | 機能性食品 |
| HUP0301336A3 (en) † | 2000-07-05 | 2005-04-28 | Biotie Therapies Corp | Inhibitors of copper-containing amine oxidases and their use for preparation of pharmaceutical compositions |
| DE10043802A1 (de) | 2000-09-06 | 2002-03-14 | Daimler Chrysler Ag | Achse für Fahrzeuge, insbesondere Nutzfahrzeuge |
| WO2002038153A1 (en) * | 2000-11-09 | 2002-05-16 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine derivatives |
| JP2002193826A (ja) * | 2000-12-26 | 2002-07-10 | Fancl Corp | 強壮・強精組成物 |
| US6982286B2 (en) † | 2001-07-12 | 2006-01-03 | Biotie Therapies Corp. | Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| CA2514573A1 (en) † | 2003-01-27 | 2004-08-12 | Astellas Pharma Inc. | Thiazole derivatives and their use as vap-1 inhibitors |
-
2005
- 2005-01-19 EP EP05708123A patent/EP1708711B1/en not_active Revoked
- 2005-01-19 PT PT05708123T patent/PT1708711E/pt unknown
- 2005-01-19 PL PL05708123T patent/PL1708711T3/pl unknown
- 2005-01-19 DE DE602005019974T patent/DE602005019974D1/de active Active
- 2005-01-19 ES ES05708123T patent/ES2342409T3/es active Active
- 2005-01-19 DK DK05708123.4T patent/DK1708711T3/da active
- 2005-01-19 WO PCT/FI2005/000035 patent/WO2005072738A1/en not_active Application Discontinuation
- 2005-01-19 JP JP2006550207A patent/JP2007519688A/ja active Pending
- 2005-01-19 CA CA002549029A patent/CA2549029A1/en not_active Abandoned
- 2005-01-19 SI SI200531026T patent/SI1708711T1/sl unknown
- 2005-01-19 AT AT05708123T patent/ATE460935T1/de active
-
2010
- 2010-06-11 CY CY20101100523T patent/CY1110194T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2549029A1 (en) | 2005-08-11 |
| ES2342409T3 (es) | 2010-07-06 |
| JP2007519688A (ja) | 2007-07-19 |
| ATE460935T1 (de) | 2010-04-15 |
| WO2005072738A1 (en) | 2005-08-11 |
| DE602005019974D1 (de) | 2010-04-29 |
| EP1708711A1 (en) | 2006-10-11 |
| PL1708711T3 (pl) | 2010-10-29 |
| EP1708711B1 (en) | 2010-03-17 |
| PT1708711E (pt) | 2010-06-01 |
| DK1708711T3 (da) | 2010-06-14 |
| SI1708711T1 (sl) | 2010-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110194T1 (el) | Ενωσεις ιδιαιτερα χρησιμες για την αγωγη ή προληψη του μεταβολικου συνδρομου | |
| PH12021550756A1 (en) | Compositions and methods for treating and/or preventing cardiovascular disease | |
| WO2007093450A3 (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds | |
| UA96124C2 (ru) | Фармацевтический пенный состав, который включает имиквимод | |
| TW200744639A (en) | Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents | |
| NO20075009L (no) | Ernaeringstilsetning for HIV-pasienter | |
| NI201200072A (es) | Métodos y composiciones para tratar cáncer | |
| ATE511764T1 (de) | Silizium enthaltende lebensmittel | |
| DK1804589T3 (da) | Fedtsammensætninger | |
| MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
| TW200637547A (en) | Compounds and compositions as protein kinase inhibitors | |
| EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
| IL178727A (en) | Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same | |
| NO343256B1 (no) | Flavonoid-sukker-addisjonsprodukt samt anvendelse derav og preparat | |
| HK1086548A1 (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds | |
| MY146444A (en) | Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases | |
| TW200716653A (en) | Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases | |
| WO2007120725A3 (en) | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive | |
| MY146803A (en) | Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors | |
| EA200870187A1 (ru) | Пищевой продукт с гасителем вкуса и способ его изготовления | |
| EA200701180A1 (ru) | Способ и промежуточные продукты для получения канфосфамида и его солей, фармацевтические композиции, содержащие некоторые промежуточные продукты и их применение в качестве противораковых средств | |
| DE602007007784D1 (de) | Präbiotikumhaltiges flüssiges nahrungsmittelprodukt | |
| TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
| DK1729598T3 (da) | Præparat, anvendelse af et præparat og en fremgangsmåde til forebyggelse af fedtabsorption | |
| TH154894A (th) | ผลิตภัณฑ์นมหมักชนิดใหม่ และวิธีการสำหรับการผลิตสิ่งเดียวกันนี้ |